BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32530990)

  • 1. Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action.
    Allescher HD; Burgell R; Malfertheiner P; Mearin F
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):227-233. PubMed ID: 32530990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target.
    Allescher HD; Abdel-Aziz H
    Dig Dis; 2017; 35 Suppl 1():18-24. PubMed ID: 29421789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
    Lapina TL; Trukhmanov AS
    Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.
    Thumann TA; Pferschy-Wenzig E-M; Kumpitsch C; Duller S; Högenauer C; Kump P; Aziz-Kalbhenn H; Ammar RM; Rabini S; Moissl-Eichinger C; Bauer R
    Microbiol Spectr; 2024 Jun; 12(6):e0403123. PubMed ID: 38738925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids.
    Elbadawi M; Ammar RM; Aziz-Kalbhenn H; Rabini S; Klauck SM; Dawood M; Saeed MEM; Kampf CJ; Efferth T
    Phytomedicine; 2021 Jul; 88():153589. PubMed ID: 34111617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.
    Chang FY
    World J Gastroenterol; 2014 Mar; 20(10):2499-514. PubMed ID: 24627587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.
    Yaklai K; Pattanakuhar S; Chattipakorn N; Chattipakorn SC
    Am J Chin Med; 2021; 49(2):285-314. PubMed ID: 33622207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.
    Devanarayana NM; Rajindrajith S
    World J Gastroenterol; 2018 Jun; 24(21):2211-2235. PubMed ID: 29881232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome: a clinical review.
    Chey WD; Kurlander J; Eswaran S
    JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
    Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
    Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?
    Ma XP; Hong J; An CP; Zhang D; Huang Y; Wu HG; Zhang CH; Meeuwsen S
    World J Gastroenterol; 2014 May; 20(20):6044-54. PubMed ID: 24876727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
    Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
    Delvaux M
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):747-71. PubMed ID: 15324712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of psychological stress on irritable bowel syndrome.
    Qin HY; Cheng CW; Tang XD; Bian ZX
    World J Gastroenterol; 2014 Oct; 20(39):14126-31. PubMed ID: 25339801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
    Talley NJ; Holtmann G; Walker MM
    J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional findings in irritable bowel syndrome.
    Posserud I; Ersryd A; Simrén M
    World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.